SHI; Houguang

Patent Applications and Registrations

Patent applications and USPTO patent grants for SHI; Houguang.The latest application filed is for "free amino compounds for the treatment and prophylaxis of bacterial infection".

Company Profile

4.6.13

SHI; Houguang - Shanghai CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Free Amino Compounds For The Treatment And Prophylaxis Of Bacterial Infection App 20210323981 - SHEN; Hong ; et al.	2021-10-21
Tricyclic Compounds For The Treatment And Prophylaxis Of Bacterial Infection App 20210309657 - DEY; Fabian ; et al.	2021-10-07
Aryl Compounds For The Treatment And Prophylaxis Of Bacterial Infection App 20210309658 - DEY; Fabian ; et al.	2021-10-07
Novel Oxoquinolizine Compounds For The Treatment And Prophylaxis Of Bacterial Infection App 20210238197 - Dey; Fabian ; et al.	2021-08-05
Substituted Pyridoindoles For The Treatment And Prophylaxis Of Bacterial Infection App 20210221832 - DING; Xiao ; et al.	2021-07-22
Novel pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infection App 20200339603 - Hu; Yimin ; et al.	2020-10-29
Pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infection Grant 10,662,203 - Hu , et al.	2020-05-26
6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection App 20200062753 - Guo; Lei ; et al.	2020-02-27
6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection Grant 10,428,069 - Guo , et al. October 1, 2	2019-10-01
Novel 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection App 20180370969 - Guo; Lei ; et al.	2018-12-27
Novel pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infection App 20180327425 - Hu; Yimin ; et al.	2018-11-15
6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection Grant 10,081,627 - Guo , et al. September 25, 2	2018-09-25
6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection Grant 9,758,530 - Guo , et al. September 12, 2	2017-09-12
Novel 6-bridged Heteroaryldihydropyrimidines For The Treatment And Prophylaxis Of Hepatitis B Virus Infection App 20160122363 - Guo; Lei ; et al.	2016-05-05
Novel 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection App 20160083383 - Guo; Lei ; et al.	2016-03-24
6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection Grant 9,266,904 - Guo , et al. February 23, 2	2016-02-23
6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection Grant 9,233,978 - Guo , et al. January 12, 2	2016-01-12
Novel 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection App 20150252057 - Guo; Lei ; et al.	2015-09-10
Novel 6-bridged Heteroaryldihydropyrimidines For The Treatment And Prophylaxis Of Hepatitis B Virus Infection App 20140343032 - Guo; Lei ; et al.	2014-11-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.